Heard on the news yesterday Opdivo/Yervoy is now on the PBS to treat stage 3/4 melanoma in OZ. Seem to be based on a 30-50% success rate (ORR rate ?) and are still very much ahead of Keytruda/Efti. Hoping the catch up will happen with grater success.
Immutep's playing field...., page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.025(7.58%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.3¢ | 30.5¢ | $1.286M | 4.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 190736 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 94190 | 21 |
View Market Depth
| Last trade - 13.59pm 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
